IBERE PHARMACEUTICALS Quarterly Cash and Cash Equivalents, at Carrying Value in USD from Q4 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Ibere Pharmaceuticals quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q4 2020 to Q3 2022.
  • Ibere Pharmaceuticals Cash and Cash Equivalents, at Carrying Value for the quarter ending September 30, 2022 was $4.45K, a 99.3% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $4.45K -$676K -99.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $93K -$763K -89.1% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $135K -$1.08M -88.9% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $458K +$283K +161% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $680K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $856K Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $1.22M Mar 31, 2021 10-Q/A 2021-08-16
Q4 2020 $175K Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.